Welcome to LookChem.com Sign In|Join Free
  • or
C9H20N2O2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1194975-22-8

Post Buying Request

1194975-22-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1194975-22-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1194975-22-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,4,9,7 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1194975-22:
(9*1)+(8*1)+(7*9)+(6*4)+(5*9)+(4*7)+(3*5)+(2*2)+(1*2)=198
198 % 10 = 8
So 1194975-22-8 is a valid CAS Registry Number.

1194975-22-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl (R)-(2-aminobutyl)carbamate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1194975-22-8 SDS

1194975-22-8Upstream product

1194975-22-8Downstream Products

1194975-22-8Relevant academic research and scientific papers

BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS

-

Page/Page column 134, (2012/05/20)

The present invention is directed to compounds of formula I and pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of Syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition Syk kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by Syk kinase activity, such as Non Hodgkin's Lymphoma.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1194975-22-8